These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37820110)

  • 1. Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti.
    Alvarez OA; St Victor Dély N; Paul Hanna M; Saint Fleur R; Cetoute M; Metalonis S; Hustace T; Brown EC; Marcelin LH; Muscadin E; Eveillard R; Lerebours E
    Blood Adv; 2024 Jan; 8(1):14-22. PubMed ID: 37820110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned.
    Segbefia CI; Goka B; Welbeck J; Amegan-Aho K; Dwuma-Badu D; Rao S; Salifu N; Oppong SA; Odei E; Ohene-Frempong K; Odame I
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29068. PubMed ID: 33890391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
    Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
    Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Adegoke SA; Makalo L; Sallah A; Saine H; Joof S; Conteh A; Bah R; Camara Jammeh AF; Bass M; Jallow M; Nnodu OE
    Hemoglobin; 2024 May; 48(3):169-174. PubMed ID: 38980121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
    Olaniyan HS; Briscoe C; Muhongo M; Pascoal R; Armando A; Santos B; McGann PT
    Blood Adv; 2023 Oct; 7(19):5860-5867. PubMed ID: 37399450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Quality of Care Indicators and Location of Sickle Cell Care Within Indiana.
    Meier ER; Janson IA; Hampton K; Bloom E; Duncan N; Roberson C; Rampersad A
    J Community Health; 2020 Feb; 45(1):81-87. PubMed ID: 31396825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal knowledge and attitudes about newborn screening for sickle cell disease and cystic fibrosis.
    Lang CW; Stark AP; Acharya K; Ross LF
    Am J Med Genet A; 2009 Nov; 149A(11):2424-9. PubMed ID: 19876910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
    Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
    Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
    Mano RM; Kuona P; Misihairabgwi JM
    BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health education to promote knowledge about sickle cell disease and newborn screening in pregnant women: a community-based pilot study using the healthy beginning initiative.
    Ezenwosu OU; Olawepo JO; Lacroix-Willliamson LJ; Itanyi IU; Ogidi A; Onyeka TC; Gully M; Gregory M; Breeze JL; Ibemere S; Idemili-Aronu N; Molnar BE; Ezeanolue EE
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):321. PubMed ID: 38671412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Newborn screening for sickle cell disease in France].
    Brousse V; Allaf B; Benkerrou M
    Med Sci (Paris); 2021 May; 37(5):482-490. PubMed ID: 34003094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
    Lobitz S; Klein J; Brose A; Blankenstein O; Frömmel C
    Ann Hematol; 2019 Jan; 98(1):47-53. PubMed ID: 30132072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
    Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of Newborn Screening for Sickle Cell Disease among Post-Partum Mothers in Abakaliki, South East Nigeria.
    Nnachi OC; Umeokonkwo AA; Okoye HC; Ekwe AN; Akpa CO; Okoye AE
    West Afr J Med; 2023 Mar; 40(3):298-304. PubMed ID: 37017939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
    Allaf B; Patin F; Elion J; Couque N
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.